Coffee consumption and hepatocellular carcinoma in patients with HBeAg negative chronic hepatitis B

被引:1
|
作者
Chen, Chien-Lin [1 ,2 ]
Chang, Wei-Chuan [3 ]
Hsu, Ching-Sheng [2 ,4 ,5 ]
机构
[1] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[2] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Internal Med, Div Gastroenterol, Hualien, Taiwan
[3] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan
[4] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Liver Dis Res Ctr, Taipei, Taiwan
[5] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan
关键词
D O I
10.1016/j.jfma.2019.11.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:765 / 766
页数:2
相关论文
共 50 条
  • [1] DETECTION OF HBEAG IN THE LYMPHOCYTES OF SERO-HBEAG NEGATIVE PATIENTS WITH CHRONIC HEPATITIS-B AND PRIMARY HEPATOCELLULAR-CARCINOMA
    DING, JL
    OON, CJ
    CYTOBIOS, 1984, 39 (153) : 29 - 33
  • [2] Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
    Chun, Ho Soo
    Lee, Minjong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 448 - 450
  • [3] Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B
    Fung, J.
    Lai, C. -L.
    Seto, W. -K.
    Wong, D. K. -H.
    Yuen, M. -F.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : 738 - 744
  • [4] Lamivudine therapy in HBeAg negative chronic hepatitis B patients
    Guclu, E.
    Batirel, A.
    Ince, N. Koc
    Ogutlu, A.
    Durmaz, Y.
    Ozdemir, D.
    Geyik, M. F.
    Karabay, O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 444 - 444
  • [5] Management of patients with HBeAg-negative chronic hepatitis B
    Saikia, Nripen
    Talukdar, Rupjyoti
    Mazumder, Subhasish
    Khanna, Sudeep
    Tandon, Rakesh
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (975) : 32 - 39
  • [6] Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma
    Pellicelli, Adriano M.
    Vignally, Pascal
    Messina, Vincenzo
    Izzi, Antonio
    Mazzoni, Ettore
    Barlattani, Angelo
    Bacca, Donato
    Romano, Mario
    Mecenate, Fabrizio
    Stroffolini, Tommaso
    Furlan, Caterina
    Picardi, Antonio
    Gentilucci, Umberto V.
    Gulminetti, Roberto
    Bonaventura, Maria E.
    Villani, Roberto
    D'Ambrosio, Cecilia
    Paffetti, Amerigo
    Mastropietro, Cristina
    Marignani, Massimo
    Fondacaro, Lucia
    Cerasari, Giuseppe
    Andreoli, Arnaldo
    Barbarini, Giorgio
    ANNALS OF HEPATOLOGY, 2014, 13 (04) : 376 - 385
  • [7] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
    Jang, Heejoon
    Yoon, Jun Sik
    Park, Soo Young
    Lee, Han Ah
    Jang, Myoung-Jin
    Kim, Seung Up
    Sinn, Dong Hyun
    Seo, Yeon Seok
    Kim, Hwi Young
    Kim, Sung Eun
    Jun, Dae Won
    Yoon, Eileen L.
    Sohn, Joo Hyun
    Ahn, Sang Bong
    Shim, Jae-Jun
    Jeong, Soung Won
    Cho, Yong Kyun
    Kim, Hyoung Su
    Nam, Joon Yeul
    Lee, Yun Bin
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Zoulim, Fabien
    Lampertico, Pietro
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Berg, Thomas
    Buti, Maria
    Calleja, Jose Luis
    Goulis, John
    Manolakopoulos, Spilios
    La Janssen, Harry
    Papatheodoridis, George, V
    Lee, Jeong-Hoon
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : 1343 - +
  • [8] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B
    Jang, Heejoon
    Yoon, Jun Sik
    Park, Soo Young
    Lee, Han Ah
    Jang, Myoung-Jin
    Kim, Seung Up
    Sinn, Dong Hyun
    Seo, Yeon Seok
    Kim, Hwi Young
    Kim, Sung Eun
    Jun, Dae Won
    Yoon, Eileen
    Sohn, Joo Hyun
    Lee, Jun-Hyuk
    Shim, Jae-Jun
    Jeong, Soung Won
    Cho, Yong Kyun
    Kim, Hyoung Su
    Nam, Joon Yeul
    Lee, Yun Bin
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Zoulim, Fabien
    Lampertico, Pietro
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Berg, Thomas
    Buti, Maria
    Luis Calleja, Jose
    Goulis, John
    Manolakopoulos, Spilios
    Janssen, Harry L. A.
    Papatheodoridis, George
    Lee, Jeong-Hoon
    HEPATOLOGY, 2021, 74 : 485A - 486A
  • [9] Does interferon treatment reduce hepatocellular carcinoma incidence in HBeAg positive chronic hepatitis B patients?
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fukushima, Taito
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2014, 60 : 1120A - 1120A
  • [10] Laparoscopic Findings of Reddish Markings Predict Hepatocellular Carcinoma in HBeAg Positive Chronic Hepatitis B Patients
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Miyake, Yasuhiro
    Takaki, Akinobu
    Fujioka, Shin-ichi
    Kobashi, Haruhiko
    Yamamoto, Kazuhide
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S145 - S145